Bevacizumab/doxorubicin liposomalReversible posterior leukoencephalopathy syndrome: case report

被引：0
作者：
机构：
来源：
Reactions Weekly | 2008年 / 1191卷 / 1期
关键词：
Breast Cancer; Doxorubicin; Meningitis; Bevacizumab; Mannitol;
D O I：
10.2165/00128415-200811910-00015
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
[21]   BevacizumabReversible posterior leukoencephalopathy syndrome in an elderly patient: case report [J].
Reactions Weekly, 2008, 1196 (1) :9-9
[22]   BevacizumabReversible posterior leukoencephalopathy syndrome in an elderly patient: case report [J].
Reactions Weekly, 2010, 1321 (1) :10-10
[23]   BevacizumabReversible posterior leukoencephalopathy syndrome in an elderly patient: case report [J].
Reactions Weekly, 2012, 1391 (1) :13-13
[24]   Bevacizumab/sunitinibMicroangiopathic haemolytic anaemia and reversible posterior leukoencephalopathy syndrome: 5 case reports [J].
Reactions Weekly, 2009, 1243 (1) :12-12
[25]   Bevacizumab/doxorubicin liposomalDiarrhoea and fatigue: case report [J].
Reactions Weekly, 2011, 1370 (1) :10-10
[26]   Reversible posterior leukoencephalopathy syndrome induced by apatinib: a case report and literature review [J].
Li, Xutong ;
Chai, Jie ;
Wang, Zhi ;
Lu, Lin ;
Zhao, Qingye ;
Zhou, Jie ;
Ju, Fang .
ONCOTARGETS AND THERAPY, 2018, 11 :4407-4411
[27]   Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer [J].
Wei Wang ;
Li-Rong Zhao ;
Xiu-Qiang Lin ;
Fen Feng .
World Journal of Gastroenterology, 2014, (21) :6691-6697
[28]   Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer [J].
Wang, Wei ;
Zhao, Li-Rong ;
Lin, Xiu-Qiang ;
Feng, Fen .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (21) :6691-6697
[29]   Posterior reversible leukoencephalopathy syndrome secondary to hepatic transarterial chemoembolization with doxorubicin drug eluting beads [J].
Kistler, C. Andrew ;
McCall, Joseph Caleb ;
Ghumman, Saad Sultan ;
Ali, Ijlal Akbar ;
Siddiqui, Ali A. .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (02) :E43-E45
[30]   Bevacizumab/fluoxetine/marijuanaReversible cerebral vasoconstriction syndrome: case report [J].
Reactions Weekly, 2012, 1394 (1) :11-11
12345